Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing

被引:0
|
作者
Yi-Hua Jan
Kien Thiam Tan
Shu-Jen Chen
Timothy Tak Chun Yip
Cu tai Lu
Alfred King-yin Lam
机构
[1] Cancer Genomics,Department of Surgery
[2] ACT Genomics,Cancer Molecular Pathology, School of Medicine and Dentistry
[3] Co. Ltd.,undefined
[4] Medical Science,undefined
[5] ACT Genomics,undefined
[6] Co. Ltd.,undefined
[7] Gold Coast University Hospital,undefined
[8] Menzies Health Institute Queensland,undefined
[9] Gold Coast campus,undefined
[10] Griffith University,undefined
[11] Pathology Queensland,undefined
[12] Gold Coast University Hospital,undefined
来源
British Journal of Cancer | 2022年 / 127卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1304 / 1311
页数:7
相关论文
共 50 条
  • [41] Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
    Han, Sae-Won
    Kim, Hwang-Phill
    Shin, Jong-Yeon
    Jeong, Eun-Goo
    Lee, Won-Chul
    Lee, Kyung-Hun
    Won, Jae-Kyung
    Kim, Tae-Yong
    Oh, Do-Youn
    Im, Seock-Ah
    Bang, Yung-Jue
    Jeong, Seung-Yong
    Park, Kyu Joo
    Park, Jae-Gahb
    Kang, Gyeong Hoon
    Seo, Jeong-Sun
    Kim, Jong-Il
    Kim, Tae-You
    PLOS ONE, 2013, 8 (05):
  • [42] Concordance in Oncogenic Alterations between Primary and Recurrent/Metastatic Cholangiocarcinoma Pairs Using Targeted Next-Generation Sequencing
    McIntyre, Sarah M.
    Preston, William
    Walch, Henry
    Sigel, Carlie
    Sharib, Jeremy
    Chen, Wei
    Lidsky, Michael E.
    Kundra, Ritika
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Balachandran, Vinod P.
    Drebin, Jeffrey A.
    Soares, Kevin C.
    Wei, Alice C.
    Kingham, Peter
    D'Angelica, Michael I.
    Iacobuzio-Donahue, Christine
    Schultz, Nikolaus
    Jarnagin, William R.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S174 - S174
  • [43] Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay.
    Abida, Wassim
    Curtis, Kristen Rebecca
    Taylor, Barry S.
    Arcila, Maria E.
    Brennan, Ryan
    Danila, Daniel Costin
    Rathkopf, Dana E.
    Morris, Michael J.
    Slovin, Susan F.
    Solit, David B.
    Hyman, David Michael
    Gopalan, Anuradha
    Berger, Michael F.
    Schultz, Nikolaus
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations
    Mehrad, Mitra
    Roy, Somak
    Bittar, Humberto Trejo
    Dacic, Sanja
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (03) : 353 - 357
  • [45] Frequency of actionable genomic alterations in early-stage lung adenocarcinoma (LA) detected by next-generation sequencing (NGS)
    Wang, Kai
    Stephens, Philip
    Yelensky, Roman
    Ross, Jeffrey S.
    Miller, Vincent A.
    Dracopoli, Nicholas J.
    Cronin, Maureen T.
    Platero, Suso J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Identification of Genomic Aberrations in Large Cell Neuroendocrine Carcinoma of Lung by Targeted Next-Generation Sequencing
    Chun, S.
    Lee, J.
    Jeon, H.
    Kim, D.
    Lee, S.
    Ahn, S.
    Kim, J.
    Jnag, S.
    Jang, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 814 - 814
  • [47] Targeted next-generation DNA sequencing of paired tumor and normal DNA to reveal frequent actionable germline alterations.
    Korn, Wolfgang Michael
    Yey, Iwei
    Van Ziffle, Jessica
    Grenert, James P.
    Joseph, Nancy
    Solomon, David A.
    Laurance, Megan
    Talevich, Eric
    Onodera, Courtney
    Krings, Gregor
    Stohr, Bradley A.
    Blanco, Amie
    Bastian, Boris C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies
    Niu, G. G.
    Al-Rohil, R. N.
    Vanushkina, M.
    Sheehan, C. E.
    Nazeer, T.
    DiCaprio, M.
    Palmer, G.
    Ali, S. M.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    MODERN PATHOLOGY, 2014, 27 : 23A - 24A
  • [49] Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies
    Niu, G. G.
    Al-Rohil, R. N.
    Vanushkina, M.
    Sheehan, C. E.
    Nazeer, T.
    DiCaprio, M.
    Palmer, G.
    Ali, S. M.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    LABORATORY INVESTIGATION, 2014, 94 : 23A - 24A
  • [50] Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics
    Haefliger, Simon
    Marston, Katharina
    Alborelli, Ilaria
    Stauffer, Edouard-Jean
    Gugger, Mathias
    Jermann, Philip M.
    Hoeller, Sylvia
    Tornillo, Luigi
    Terracciano, Luigi M.
    Bihl, Michel
    Matter, Matthias S.
    PATHOBIOLOGY, 2023, 90 (03) : 166 - 175